Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COM
-
Number of holders
-
776
-
Total shares
-
272M
-
Shares change
-
+5.27M
-
Total reported value, excl. options
-
$10.9B
-
Value change
-
+$211M
-
Put/Call ratio
-
0.71
-
Number of buys
-
308
-
Number of sells
-
-338
-
Price
-
$40.17
Significant Holders of GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) as of Q3 2018
794 filings reported holding GSK - GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM as of Q3 2018.
GSK PLC ADR FSPONSORED ADR 1 ADR REPS 2 ORD SHS - COM (GSK) has 776 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 272M shares
.
Largest 10 shareholders include DODGE & COX (48M shares), ROYAL BANK OF CANADA (20M shares), FMR LLC (19.1M shares), PRICE T ROWE ASSOCIATES INC /MD/ (16.4M shares), Fisher Asset Management, LLC (14M shares), RENAISSANCE TECHNOLOGIES LLC (10.1M shares), STATE STREET CORP (9.93M shares), HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC (8.42M shares), BANK OF AMERICA CORP /DE/ (8.27M shares), and WELLS FARGO & COMPANY/MN (6.62M shares).
This table shows the top 776 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.